- Lobbying
- Karen AND Lynch-Calton
Lobbying Arrangements Results for 'Karen Lynch Calton'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Medicare advantage. |
POSIT SCIENCE
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Agriculture issues. |
AVID IDENTIFICATION SYSTEMS, INC
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Tax Policy |
COORS BREWING COMPANY
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details HOM - Homeland Security |
NATIONAL CENTER FOR GENOME RESOURCES
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Appropriations. |
A VOICE FOR ALL, INC.
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details GSE Legislation HR 1461 and S 190 |
FREDDIE MAC
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Health care and pharmaceutical issues within the US House and US Senate. |
GRAS/E COALITION
Pharmaceutical |
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Federal representation in regard to VA funding for speech communication devices. |
Speech For Warriors
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Health Care and pharmaceutical issues. |
FERRING PHARMACEUTICALS - USA
Pharmaceuticals |
BUCHANAN INGERSOLL & ROONEY PC | |||
Details FDA related Application issues; pricing of prescription drugs |
Breckenridge Pharmaceutical, Inc.
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Food safety issues, FDA |
Anresco, Inc.
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Health information technology; organized retail crime bill; drug pedigree legislation; health care reform; S.425 implementation; TRICARE issues; MTM legislation |
WALGREEN CO.
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Financial services reform issues including issues related to the implementation of the Emergency Economic Stabilization Act of 2008 and amendments to the Treasury's TARP program |
PNC FINANCIAL SERVICES GROUP
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Hospital provider regulations. Regulatory representation Hospital provider regulations. Regulatory representation. |
CATHOLIC HEALTH EAST
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R... |
GENERIC ANIMAL DRUG ALLIANCE
|
Buchanan Ingersoll & Rooney, PC | |||
Details Monitor energy issues, climate change and mining law reform Monitor, derivatives, commodity trading, taxation issues |
TRAFIGURA AG
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details National Defense Authorization Act and defense policy related to Traumatic Brain Injury; FY 2023 Defense Appropriations |
TEAM WENDY, LLC
|
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Pharmacy Benefit Manager Transparency Act of 2023 (S.127); Improving Seniors Timely Access To Care Act; Public Health Emergency; Medicare Advantage payment issues, from CMS; Site neutral payments; ... |
University of Pittsburgh Medical Center
|
BUCHANAN INGERSOLL & ROONEY PC |